India's patent laws under pressure.
作者信息
Roderick Peter, Pollock Allyson M
出版信息
Lancet. 2012 Sep 15;380(9846):e2-4. doi: 10.1016/s0140-6736(12)61513-x.
Abstract
摘要
相似文献
1
India's patent laws under pressure.
Lancet. 2012 Sep 15;380(9846):e2-4. doi: 10.1016/s0140-6736(12)61513-x.
2
Novartis challenges India's drug patent laws in Supreme Court.
BMJ. 2012 Feb 21;344:e1279. doi: 10.1136/bmj.e1279.
3
Intellectual property. Challenges to India's pharmaceutical patent laws.
Science. 2012 Jul 27;337(6093):414-5. doi: 10.1126/science.1224892. Epub 2012 Jul 5.
4
India's new patent laws may still hurt generic drug supplies.
Lancet. 2005;365(9468):1378. doi: 10.1016/S0140-6736(05)66356-8.
5
Legal challenge to India's patent laws threatens access to generic drugs, says charity.
BMJ. 2011 Sep 9;343:d5753. doi: 10.1136/bmj.d5753.
6
India's patent case victory rattles Big Pharma.
Lancet. 2013 Apr 13;381(9874):1263. doi: 10.1016/s0140-6736(13)60826-0.
7
India's new patent bill threatens generic industry.
Lancet Infect Dis. 2005 May;5(5):265. doi: 10.1016/s1473-3099(05)70099-2.
8
Patent dispute: Delhi High Court gives a boost to access to affordable medicines.
Indian J Med Ethics. 2010 Apr-Jun;7(2):97-100. doi: 10.20529/IJME.2010.033.
9
Changes to India's patent law may deny cheap drugs to millions.
BMJ. 2005 Mar 26;330(7493):692. doi: 10.1136/bmj.330.7493.692.
10
Big Pharma vs India’s Patent Office.
Pharm Pat Anal. 2012 Nov;1(5):529. doi: 10.4155/ppa.12.72.
引用本文的文献
1
"To patent or not to patent? the case of Novartis' cancer drug Glivec in India".
Global Health. 2014 Jan 6;10:3. doi: 10.1186/1744-8603-10-3.
Zotero 插件